Vaccinex Provides Update on ActivMAb® Platform: Multiple Project Deals and Presentation at SITC
Vaccinex has global commercial and development rights to pepinemab and is the sponsor of the KEYNOTE-B84 study which is being performed in collaboration with Merck Sharp & Dohme Corp, a subsidiary of ...
Electronic Design5d
11 Myths About Electric-Vehicle Batteries
Explore several of the most common misconceptions about EV batteries and one of the most promising new technologies in the ...